U.S. Markets open in 1 hr 9 mins

Imprimis Pharmaceuticals, Inc. (IMMY)


NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
3.03+0.07 (+2.36%)
At close: 4:00PM EDT
People also watch
EVOKDPRXOCRXINNLHTBX
Full screen
Previous Close2.96
Open2.92
Bid2.85 x 200
Ask3.74 x 300
Day's Range2.83 - 3.14
52 Week Range1.65 - 4.69
Volume156,125
Avg. Volume169,407
Market Cap60.8M
Beta1.38
PE Ratio (TTM)-2.30
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cubelast month

    ETFs with exposure to Imprimis Pharmaceuticals, Inc. : June 19, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Imprimis Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to IMMY-US. Comparing the performance and risk of Imprimis Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cubelast month

    ETFs with exposure to Imprimis Pharmaceuticals, Inc. : June 8, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Imprimis Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to IMMY-US. Comparing the performance and risk of Imprimis Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Imprimis Pharmaceuticals, Inc. :IMMY-US: Earnings Analysis: Q1, 2017 By the Numbers : June 6, 2017
    Capital Cubelast month

    Imprimis Pharmaceuticals, Inc. :IMMY-US: Earnings Analysis: Q1, 2017 By the Numbers : June 6, 2017

    Categories: Yahoo FinanceGet free summary analysis Imprimis Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Imprimis Pharmaceuticals, Inc. – Akorn, Inc., Antares Pharma, Inc., Retractable Technologies, Inc., Delcath Systems, Inc., ICU Medical, Inc. and Tandem Diabetes Care, Inc. (AKRX-US, ATRS-US, RVP-US, DCTH-US, ICUI-US ... Read more (Read more...)